Regeneron Pharmaceuticals | 应收帐款人



Trade Debtors 更改 日
AbbVie USD 10.92B 553M 2024-12
Agios Pharmaceuticals USD 4.11M 991K 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amgen USD 6.78B 535M 2024-12
Astellas Pharma JPY 646.22B 11.38B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
J&J USD 16.02B 1.18B 2025-03
Kyowa Hakko Kirin JPY 136.49B 20.52B 2025-03
Merck USD 11.12B 1.06B 2024-12
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 5.56B 650.9M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 10.63B 1.82B 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Teva Pharmaceutical Industries USD 3.06B 403M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
United Therapeutics USD 322M 42.7M 2025-03
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Regeneron Pharmaceuticals 应收帐款人 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2025.